Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mateon Therapeutics Inc (NASDAQ:MATN)

0.605
Delayed Data
As of Sep 28
 +0.005 / +0.83%
Today’s Change
0.49
Today|||52-Week Range
1.23
-20.38%
Year-to-Date
No recent news for Mateon Therapeutics Inc.

Today’s Trading

Previous close0.60
Today’s open0.61
Day’s range0.60 - 0.62
Volume105,640
Average volume (3 months)362,374
Market cap$15.9M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+28.00%
Earnings growth (this year)-5.56%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
WGBSWaferGen Bio-systems...-0.01-1.11%
STEMStemCells Inc-0.01-0.71%
----
RGBPRegen BioPharma Inc-0.01-4.69%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$13.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
William D. Schwieterman
Chief Financial &
Accounting Officer
Matthew M. Loar
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs